| Zeit | Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 03.05. | American Oncology Network Announces CFO Transition | 251 | GlobeNewswire (Europe) | FORT MYERS, Fla., May 03, 2024 (GLOBE NEWSWIRE) -- American Oncology Network ("AON" or the "Company") (Nasdaq: AONC), a rapidly growing network of community-based oncology practices, announced today... ► Artikel lesen | |
| 03.05. | Newbury Street Acquisition Corporation Announces Receipt of Nasdaq Letter | 129 | GlobeNewswire (Europe) | Boston, MA, May 03, 2024 (GLOBE NEWSWIRE) -- Newbury Street Acquisition Corporation (NASDAQ: NBST, the "Company") announced today that it received a letter dated April 24, 2024, from the Listing Qualifications... ► Artikel lesen | |
| 03.05. | Praxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | 79 | GlobeNewswire (Europe) | BOSTON, May 03, 2024 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (Nasdaq: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies... ► Artikel lesen | |
| 03.05. | Mersana Therapeutics, Inc.: Mersana Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | 117 | GlobeNewswire (Europe) | CAMBRIDGE, Mass., May 03, 2024 (GLOBE NEWSWIRE) -- Mersana Therapeutics, Inc. (NASDAQ:MRSN), a clinical-stage biopharmaceutical company focused on discovering and developing a pipeline of antibody-drug... ► Artikel lesen | |
| 03.05. | Dianthus Therapeutics, Inc.: Dianthus Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | 84 | GlobeNewswire (Europe) | NEW YORK and WALTHAM, Mass., May 03, 2024 (GLOBE NEWSWIRE) -- Dianthus Therapeutics, Inc. ("Dianthus"), a clinical-stage biotechnology company dedicated to advancing the next generation of antibody... ► Artikel lesen | |
| 03.05. | Jayud Global Logistics Ltd: Jayud Global Logistics Receives Nasdaq Notification of Non-Compliance with Listing Rule 5550(b) | 123 | GlobeNewswire (Europe) | SHENZHEN, China, May 03, 2024 (GLOBE NEWSWIRE) -- Jayud Global Logistics Limited (NASDAQ: JYD) ("Jayud" or the "Company"), a leading end-to-end supply chain solution provider based in Shenzhen, specializing... ► Artikel lesen | |
| 03.05. | Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) | 63 | GlobeNewswire (Europe) | MALVERN, Pa., May 03, 2024 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing, and marketing products that improve... ► Artikel lesen | |
| 03.05. | ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) | 62 | GlobeNewswire (Europe) | SOUTH SAN FRANCISCO and SAN DIEGO, May 03, 2024 (GLOBE NEWSWIRE) -- ORIC Pharmaceuticals, Inc. (Nasdaq:ORIC), a clinical stage oncology company focused on developing treatments that address mechanisms... ► Artikel lesen | |
| 03.05. | Territorial Bancorp Inc. Announces First Quarter 2024 Results | 108 | GlobeNewswire (Europe) | The Company's tier one leverage and risk-based capital ratios were 11.58% and 28.84%, respectively, and the Company is considered to be "well-capitalized" at March 31, 2024.Ratio of non-performing... ► Artikel lesen | |
| 03.05. | electroCore, Inc.: electroCore Announces Inducement Grant under NASDAQ Listing Rule 5635(c)(4) | 117 | GlobeNewswire (Europe) | ROCKAWAY, N.J., May 03, 2024 (GLOBE NEWSWIRE) -- electroCore, Inc. (the "Company"), (NASDAQ: ECOR), a commercial-stage bioelectronic medicine and wellness company, today announced that on May 1, 2024... ► Artikel lesen | |
| 03.05. | Terns Pharmaceuticals, Inc.: Terns Pharmaceuticals Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(C)(4) | 80 | GlobeNewswire (Europe) | FOSTER CITY, Calif., May 03, 2024 (GLOBE NEWSWIRE) -- Terns Pharmaceuticals, Inc. ("Terns" or the "Company") (Nasdaq: TERN), a clinical-stage biopharmaceutical company developing a portfolio of small-molecule... ► Artikel lesen | |
| 03.05. | Kernel Group Holdings, Inc. Extends Period to Consummate Initial Business Combination | 76 | GlobeNewswire (Europe) | New York, May 03, 2024 (GLOBE NEWSWIRE) -- Kernel Group Holdings, Inc. (NASDAQ: KRNLU, KRNL, KRNLW) ("KRNL" or the "Company"), a special purpose acquisition company, announced today that it has elected... ► Artikel lesen | |
| 03.05. | Taysha Gene Therapies, Inc.: Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) | 68 | GlobeNewswire (Europe) | DALLAS, May 03, 2024 (GLOBE NEWSWIRE) -- Taysha Gene Therapies, Inc. (Nasdaq: TSHA), a clinical-stage gene therapy company focused on developing and commercializing AAV-based gene therapies for the... ► Artikel lesen | |
| 03.05. | Anika Therapeutics Inc.: Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | 63 | GlobeNewswire (Europe) | BEDFORD, Mass., May 03, 2024 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today announced that on May 1, 2024... ► Artikel lesen | |
| 03.05. | NewAmsterdam Pharma Company N.V.: NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | 111 | GlobeNewswire (Europe) | NAARDEN, the Netherlands and MIAMI, May 03, 2024 (GLOBE NEWSWIRE) -- NewAmsterdam Pharma Company N.V. (Nasdaq: NAMS or "NewAmsterdam" or the "Company"), a late-stage, clinical biopharmaceutical company... ► Artikel lesen | |
| 03.05. | Vor Biopharma: Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) | 92 | GlobeNewswire (Europe) | CAMBRIDGE, Mass., May 03, 2024 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a clinical-stage cell and genome engineering company, today announced that, effective as of May 1, 2024, the Compensation... ► Artikel lesen | |
| 03.05. | Verve Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4) | 82 | GlobeNewswire (Europe) | BOSTON, May 03, 2024 (GLOBE NEWSWIRE) -- Verve Therapeutics, a clinical-stage biotechnology company pioneering a new approach to the care of cardiovascular disease with single-course gene editing... ► Artikel lesen | |
| 03.05. | Arcutis Biotherapeutics, Inc.: Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | 204 | GlobeNewswire (Europe) | WESTLAKE VILLAGE, Calif., May 03, 2024 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a commercial-stage biopharmaceutical company focused on developing meaningful innovations in... ► Artikel lesen | |
| 03.05. | Mural Oncology, Inc.: Mural Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | 96 | GlobeNewswire (Europe) | WALTHAM, Mass and DUBLIN, May 03, 2024 (GLOBE NEWSWIRE) -- Mural Oncology plc (Nasdaq: MURA), a clinical-stage immuno-oncology company leveraging its core competencies in immune cell modulation and... ► Artikel lesen | |
| 03.05. | BioSig Technologies, Inc. Announces New Appointments to its Now Fully Constituted Board of Directors, which is Comprised of 5 Board Members, 3 Independent | 64 | GlobeNewswire (Europe) | Westport, CT, May 03, 2024 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) or ("BioSig" or "the Company"), a medical technology company delivering unprecedented accuracy and precision... ► Artikel lesen |
Seite:
1 2 3 4 5 Weiter >>
| Suchbegriffe der letzen 24 h | Anzahl |
|---|---|
| GAMESTOP | 3.271 |
| EVOTEC | 2.616 |
| TUI | 2.061 |
| NEL | 1.318 |
| BAYER | 1.135 |
| PLUG POWER | 1.126 |
| NVIDIA | 1.118 |
| RHEINMETALL | 1.044 |
| AMC ENTERTAINMENT | 1.030 |
| DEUTSCHE BANK | 941 |
| SIEMENS ENERGY | 924 |
| RENK GROUP | 870 |
| REDCARE PHARMACY | 721 |
| COMMERZBANK | 720 |
| HEIDELBERGER DRUCK | 698 |
| ALIBABA | 671 |
| VOLKSWAGEN | 666 |
| E.ON | 610 |
| BARRICK GOLD | 605 |
| BYD | 583 |
| RWE | 579 |
| SIEMENS | 561 |
| TESLA | 555 |
| AIXTRON SE | 554 |
| DEUTSCHE LUFTHANSA | 550 |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und
